Treatment of Children and Adolescents With Tics and Tourette Syndrome

Abstract

Tics, patterned movements distinct from stereotypies, myoclonus, and other hyperkinetic movements, are quite common in children, particularly among those with developmental and psychiatric disorders. Thus, tics can indicate the presence of atypical neurodevelopment or broader difficulties with cognition or mood. Tics are also the cardinal feature of Tourette syndrome, a childhood-onset neurobehavioral disorder characterized by a chronic inability to suppress or an urge to perform patterned, repetitive movements. Patients with Tourette syndrome most commonly have, in addition to tics, symptoms of inattention, hyperactivity, obsessiveness, or anxiety. Achieving the most effective treatment of a child with tics is contingent on proper diagnosis of the movement disorder and thorough assessment for other problems, followed by consideration of both nonpharmacologic and pharmacologic interventions for any and all symptoms interfering with the child's function and quality of life. This review focuses primarily on the diagnosis and medical treatment of tics in children and adolescents with Tourette syndrome. (J Child Neurol 2006;21:690—700; DOI 10.2310/ 7010.2006.00161).

Get full access to this article

View all access options for this article.

References

Leckman JF , Bloch MH , Scahill L. , King RA : Tourette syndrome: The self under siege. J Child Neurol 2006;21:642—649.

Singer HS : Tourette's syndrome: From behaviour to biology. Lancet Neurol 2005;4:149—159.

Leckman JF : Tourette's syndrome. Lancet 2002;360:1577—1586.

Singer HS : Current issues in Tourette syndrome. Mov Disord 2000;15:1051—1063.

Jankovic J. : Tourette's syndrome. N Engl J Med 2001;345:1184— 1192.

Mink JW : Basal ganglia dysfunction in Tourette's syndrome: A new hypothesis. Pediatr Neurol 2001;25:190—198.

Peterson BS , Leckman JF : The temporal dynamics of tics in Gilles de la Tourette syndrome. Biol Psychiatry 1998;44:1337— 1348.

Drake ME Jr, Hietter SA , Bogner JE , Andrews JM : Cassette EEG sleep recordings in Gilles de la Tourette syndrome. Clin Electroencephalogr 1992;23:142—146.

Silvestri R. , De Domenico P. , Di Rosa AE , et al: The effect of nocturnal physiological sleep on various movement disorders. Mov Disord 1990;5:8—14.

10.

Lowe TL , Cohen DJ , Detlor J. , et al: Stimulant medications precipitate Tourette's syndrome. JAMA 1982;247:1729—1731.

11.

Price RA , Leckman JF , Pauls DL , et al: Gilles de la Tourette's syndrome: Tics and central nervous system stimulants in twins and nontwins. Neurology 1986;36:232—237.

12.

Leckman JF , Zhang H. , Vitale A. , et al: Course of tic severity in Tourette syndrome: The first two decades . Pediatrics 1998;102(1 Pt 1):14—19.

13.

Bloch MH , Peterson BS , Scahill L. , et al: Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006;160: 65—69.

14.

Mahone EM , Bridges D. , Prahme C. , Singer HS : Repetitive arm and hand movements (complex motor stereotypies) in children . J Pediatr 2004; 145:391-395.

15.

Scahill LD , Leckman JF , Marek KL : Sensory phenomena in Tourette's syndrome. Adv Neurol 1995;65:273—280.

16.

Hallett M. : Is dystonia a sensory disorder? Ann Neurol 1995;38: 139—140.

17.

Kaji R. , Rothwell JC , Katayama M. , et al: Tonic vibration reflex and muscle afferent block in writer's cramp. Ann Neurol 1995;38:155— 162.

18.

Dooley JM , Gordon KE , Wood EP , et al: The utility of the physical examination and investigations in the pediatric neurology consultation. Pediatr Neurol 2003;28:96—99.

19.

Gilbert DL , Gartside P. : Factors affecting the yield of pediatric EEGs in clinical practice. Clin Pediatr 2002;41:25—32.

20.

Gilbert DL , Sethuraman G. , Kotagal U. , Buncher CR : Meta-analysis of EEG test performance shows wide variation among studies. Neurology 2003;60:564—570.

21.

American Psychiatric Association : DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000.

22.

Zinner SH : Tourette syndrome: Much more than tics. Contemp Pediatr 2004;21:22—49.

23.

Freeman RD , Fast DK , Burd L. , et al: An international perspective on Tourette syndrome: Selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000;42:436—447.

24.

Snider LA , Seligman LD , Ketchen BR , et al: Tics and problem behaviors in schoolchildren: Prevalence, characterization, and associations. Pediatrics 2002;110(2 Pt 1):331—336.

25.

Kurlan R. , Como PG , Miller B. , et al: The behavioral spectrum of tic disorders: A community-based study. Neurology 2002;59:414— 420.

26.

Comings DE , Comings BG : Clinical and genetic relationships between autism-pervasive developmental disorder and Tourette syndrome: A study of 19 cases. Am J Med Genet 1991; 39:180—191.

27.

American Academy of Pediatrics : Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 2001;108:1033—1044.

28.

Pauls DL , Cohen DJ , Kidd KK , Leckman JF : Tourette syndrome and neuropsychiatric disorders: Is there a genetic relationship? Am J Hum Genet 1988;43:206—217.

29.

Comings DE : A controlled study of Tourette syndrome. VII. Summary: A common genetic disorder causing disinhibition of the limbic system. Am J Hum Genet 1987;41:839—866.

30.

Brodie MJ , Chadwick DW , Anhut H. , et al: Gabapentin versus lamotrigine monotherapy: A double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002 ;43:993—1000.

31.

Hesdorffer DC , Ludvigsson P. , Olafsson E. , et al: ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004;61:731—736.

32.

Franks RP : Psychiatric issues of childhood seizure disorders. Child Adolesc Psychiatr Clin N Am 2003;12:551—565.

33.

Patten SB , Fridhandler S. , Beck CA , Metz LM : Depressive symptoms in a treated multiple sclerosis cohort. Mult Scler 2003;9:616—620.

34.

Patten SB , Metz LM : Depression in multiple sclerosis. Psychother Psychosom 1997;66:286—292.

35.

Taragano FE , Allegri R. , Vicario A. , et al: A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of `vascular depression.' Int J Geriatr Psychiatry 2001;16:254—260.

36.

O'Brien JT , Erkinjuntti T. , Reisberg B. , et al: Vascular cognitive impairment. Lancet Neurol 2003;2:89—98.

37.

Robinson RG : Poststroke depression: Prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003;54: 376—387.

38.

Mindham RH , Marsden CD , Parkes JD : Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disability. Psychol Med 1976;6:23—33.

39.

Klaassen T. , Verhey FR , Sneijders GH , et al: Treatment of depression in Parkinson's disease: A meta-analysis. J Neuropsychiatry Clin Neurosci 1995;7:281—286.

40.

Bonelli RM , Wenning GK , Kapfhammer HP : Huntington's disease: Present treatments and future therapeutic modalities . Int Clin Psychopharmacol 2004;19:51—62.

41.

Gilbert DL , Buncher CR : Assessment of scientific and ethical issues in two randomized clinical trial designs for patients with Tourette's syndrome: A model for studies of multiple neuropsychiatric diagnoses. J Neuropsychiatry Clin Neurosci 2005;17: 324—332.

42.

Tourette Syndrome Study Group: Treatment of ADHD in children with tics: A randomized controlled trial. Neurology 2002;58:527— 536.

43.

Dobbs M. , Berger JR : Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology 2003;60:1862—1863.

44.

Krauss JK , Jankovic J. : Severe motor tics causing cervical myelopathy in Tourette's syndrome. Mov Disord 1996;11:563—566.

45.

Muroi A. , Matsmura A. , Asakawa H. , et al: Myelopathy caused by tics in an adolescent, associated with T2 signal intensity changes of the spinal cord. Childs Nerv Syst 2002;18:191—194.

46.

Denckla MB : Attention-Deficit Hyperactivity Disorder (ADHD) comorbidity: A case for ``pure'' Tourette syndrome? J Child Neurol 2006;21:701—703.

47.

Goodman WK , Storch EA , Geffken GR , Murphy TK : Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol 2006; 21:704—714.

48.

Nicolson R. , Craven-Thuss B. , Smith J. , et al: A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder. J Am Acad Child Adolesc Psychiatry 2005;44:640—646.

49.

Anca MH , Giladi N. , Korczyn AD : Ropinirole in Gilles de la Tourette syndrome. Neurology 2004;62:1626—1627.

50.

Toren P. , Weizman A. , Ratner S. , Cohen D. , Laor N. : Ondansetron treatment in Tourette's disorder: A 3-week, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2005;66:499— 503.

51.

Awaad Y. , Michon AM , Minarik S. : Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 2005;20:714—718.

52.

Robertson MM : Tourette syndrome, associated conditions and the complexities of treatment . Brain 2000;123 Pt 3:425—462.

53.

Singer HS , Wendlandt J. , Krieger M. , Giuliano J. : Baclofen treatment in Tourette syndrome: A double-blind, placebo-controlled, crossover trial. Neurology 2001;56:599—604.

54.

Awaad Y. : Tics in Tourette syndrome: New treatment options. J Child Neurol 1999;14:316—319.

55.

Chapel JL , Brown N. , Jenkins RL : Tourette's disease: Symptomatic relief with haloperidol. Am JPsychiatry 1964;121:608—610.

56.

Silva RR , Muñoz DM , Daniel W. , et al: Causes of haloperidol discontinuation in patients with Tourette's disorder: Management and alternatives. J Clin Psychiatry 1996;57:129—135.

57.

Gilbert DL , Batterson JR , Sethuraman G. , Sallee FR : Tic reduction with risperidone vs. pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry 2004;43: 206—214.

58.

Bruggeman R. , van der Linden C. , Buitelaar JK , et al: Risperidone versus pimozide in Tourette's disorder: A comparative double-blind parallel-group study. J Clin Psychiatry 2001;62:50—56.

59.

Ratzoni G. , Gothelf D. , Brand-Gothelf A. , et al: Weight gain associated with olanzapine and risperidone in adolescent patients: A comparative prospective study. J Am Acad Child Adolesc Psychiatry 2002;41:337—343.

60.

Gilbert D. , Singer HS : Commentary: ``Risperidone was as effective as pimozide for Tourette's disorder.'' Evid Based Ment Health 2001;4:75.

61.

Gilbert DL , Dure L. , Sethuraman G. , et al: Tic reduction with pergolide in a randomized controlled trial in children. Neurology 2003;60:606—611.

62.

Black KJ , Mink JW : Response to levodopa challenge in Tourette syndrome. Mov Disord 2000;15:1194—1198.

63.

Allen AJ , Kurlan RM , Gilbert DL , et al: Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 2005 ;65:1941—1949.

64.

Michelson D. , Faries D. , Wernicke J. , et al: Atomoxetine in the treatment of children and adolescents with attention-deficit/ hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics 2001;108:E83.

65.

Michelson D. , Allen AJ , Busner J. , et al: Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. Am J Psychiatry 2002;159:1896—1901.

66.

Visser-Vandewalle V. , Temel Y. , Boon P. , et al: Chronic bilateral thalamic stimulation: A new therapeutic approach in intractable Tourette syndrome. Report of three cases. JNeurosurg 2003;99: 1094—1100.

67.

Garvey MA , Perlmutter SJ , Allen AJ , et al: A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999;45:1564— 1571.

68.

Snider LA , Lougee L. , Slattery M. , et al: Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 2005;57:788—792.

69.

Pediatric Ocd Treatment Study Team: Cognitive-behavior therapy sertraline, and their combination for children and adolescents with obsessive-compulsive disorder, The Pediatric OCD Treatment Study randomized controlled trial. JAMA 2004; 292:1969—1976.